4 курс / Дерматовенерология / Розацеа

148.Determination of tear and serum inflammatory cytokines in patients with rosacea using multiplex bead technology / P. Topcu-Yilmaz [et al.] // Ocul. Immunol. Inflamm. – 2013. – Vol. 21, № 5. –Р. 351–359.

149.Effect of lactoferrin on the ferroxidase activity of ceruloplasmin

/A. V. Sokolov [et al.] // Biochemistry (Mosc). – 2005. – Vol. 70, № 9. – Р. 1015–1019.

150.Elewski, B. E. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results

of a randomized trial / B. E. Elewski, A. B. Jr. Fleischer,

D.M. Pariser // Cutis. – 2003. – Vol. 139, № 11. – Р. 1444–1450.

151.Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis / A. Bewley [et al.] // Dermatol. Ther. (Heidelb). – 2016. – Vol. 6, № 2. – Р. 237–247.

152.Evidence for a critical role of ceruloplasmin oxidase activity in iron metabolism of Wilson disease gene knockout mice / U. Merle [et al.] // J. Gastroenterol. Hepatol. – 2010. – Vol. 25, № 6. – Р. 1144–1150.

153.Expression of vascular endothelial growth factor and its receptors in rosacea / J. R. Smith [et al.] // Br. J. Ophthalmol. – 2007. – Vol. 91, № 2. – P. 226–229.

154.Fernandez-Obregon, A. The role of Chlamydia pneumoniae in the

etiology of acne rosacea: response to the use of oral azithromycin / A. Fernandez-Obregon, D. L. Patton // Cutis. – 2007. – Vol. 79, № 2. – Р. 163–167.

155.Ferrara, N. The biology of VEGF and its receptors / N. Ferrara, H. P. Gerber, J. LeCouter // Nat. Med. – 2003. – Vol. 9, № 6. – Р. 669–676.

156.Findley, K. Topographic diversity of fungal and bacterial communities in human skin / K. Findley [et al.] // Nature. – 2013. – Vol. 498 (7454). – Р. 367–370.

157.Forton, F. M. Papulopustular rosacea, skin immunity and

Demodex: pityriasis folliculorum as a missing link / F. M. Forton

//J. Eur. Acad. Dermatol. Venereol. – 2012. – Vol. 26, № 1. – Р. 19–28.

158.Fowler, J. F. Jr. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release

159.Gabay, C. IL-1 pathways in inflammation and human diseases

/C. Gabay, C. Lamacchia, G. Palmer // Nat. Rev. Rheumatol. – 2010. –

Vol. 6, № 4. – Р. 232–241.

~111 ~

160. Goldberg, D. J. Combination blue (415 nm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris / D. J. Goldberg, B. A. Russell // J. Cosmet. Laser Ther. – 2006. – Vol. 8,

№2. – Р. 71–75.

161.Grice, E. A. The skin microbiome: potential for novel diagnostic and therapeutic approaches to cutaneous disease / E. A. Grice // Semin. Cutan. Med. Surg. – 2014. – Vol. 33, № 2. – Р. 98–103.

162.GSTM1 and GSTT1 null genotypes as possible heritable factors of rosacea / A. C. Yazici [et al.] // Photodermatol. Photoimmunol. Photomed.

– 2006. – Vol. 22, № 4. – Р. 208–210.

163.Guffey, J. S. In vitro bactericidal effects of 405-nm and 470-nm blue light / J. S. Guffey, J. Wilborn // Photomed. Laser Surg. – 2009. –

Vol. 24, № 6. – Р. 684–688.

164. Gupta, A. K. Rosacea and its management: an overview / A. K. Gupta, M. M. Chaudhry // J. Eur. Acad. Dermatol. Venereol. – 2005.

–Vol. 19. – P. 273–285.

165.Jackson, J. M. Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea / J. M. Jackson, H. Kircik, D. J. Lorenz // J. Drugs. Dermatol. – 2013. – Vol. 12, № 3. – P. 292–298.

166.Jarmolik, E. Rola czynnika wzrostu srodblonka naczyniowego

/E. Jarmolik, D. Chworyk // 11-я Академия дерматологии и аллергологии : тез. междунар. науч.-практ. конф., Устка (Польша), 5-8 февр. 2015 г. –

Устка, 2015. – С. 98.

167.Jones, D. A. Rosacea, reactive oxygen species, and azelaic Acid

/D. A. Jones // J. Clin. Aesthet. Dermatol. – 2009. – Vol. 2, № 1. – P. 26–30.

168. Jones, D. Reactive oxygen species and rosacea / D. Jones

//Cutis. – 2004. – Vol. 74, № 3. – P. 17–20.

169.Health-related quality of life in patients with cutaneous rosacea: a systematic review / M. M. van der Linden [et al.] // Acta Derm. Venereol. – 2015. – Vol. 95, № 4. – Р. 395–400.

170.Holmes, A. D. Potential role of microorganisms in the pathogenesis of rosacea / A. D. Holmes // J. Am. Acad. Dermatol. – 2013. –

Vol. 69, № 6. – Р. 1025–1032.

171.Horiuchi, Y. FK506 (tacrolimus) inhibition of intracellular production and enhancement of interleukin 1alpha through glucocorticoid application to chemically treated human keratinocytes / Y. Horiuchi,

~112 ~

S. Bae, I. Katayama // Skin Pharmacol. Physiol. – 2005. – Vol. 18, № 5. – Р. 241–246.

172. Human Microbiome: When a Friend Becomes an Enemy

/M. Muszer [et al.] // Arch. Immunol. Ther. Exp. (Warsz.). – 2015. –

Vol. 63, № 4. – Р. 287–298.

173.Kaszuba-Bartkowiak, K. The assessment of bacterial flora and antibiotic-sensitivity of bacteria isolated from conjunctival sac, skin of the eyelids and inflammatory lesions in patients with acne vulgaris and rosacea

/K. Kaszuba-Bartkowiak, R. Goś // Przegl. Lek. – 2007. – Vol. 64, № 12. –

P. 991–996.

174.Khvorik, D. Lipid peroxidation and antioxidant protection in

patients with papulo-pustular rosacea / D. Khvoryk, A. Yarmolik

//Progress in health sciences. – 2015. – Vol. 5, № 2. – Р. 54–60.

175.Khvorik, D. Treatment of papulo-pustular rosacea using blue and red light / D. Khvorik, A. Yarmolik // 12-я Академия дерматологии и аллергологии : тез. междунар. науч.-практ. конф., Устка (Польша), 5–7 февр. 2016 г. – Устка, 2016. – С. 70–71.

176.Kökçam, I. M. Antioxidants and lipid peroxidation status in the blood of patients with psoriasis / I. Kökçam, M. Naziroğlu // Clin. Chim. Acta. – 1999. – Vol. 289, № 1/2. – P. 23–31.

177.Lee, S. Y. Blue and red light combination LED phototherapy for

acne vulgaris in patients with skin phototype IV / S. Y. Lee, C. E. You, M. Y. Park // Lasers Surg. Med. – 2007. – Vol. 39, № 2. –

179.Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations

/J. Frostegаrd [et al.] // Arthritis Rheum. – 2005. – Vol. 52 (1). – P. 192–200.

180.Low-power light and isolated rat hearts after ischemia of myocardium / V. Monich [et al.] // J. Photochem. Photobiol. – 2011. – Vol. 105, № 1. – Р. 21–24.

181.Lymphangiogenesis and angiogenesis in non-phymatous rosacea

/A. H. Gomaa [et al.] // J. Cutan. Pathol. – 2007. – Vol. 34, № 10. – Р. 748– 753.

182.Major pathophysiological correlations of rosacea: a complete clinical appraisal / R. C. Vemuri [et al.] // Int. J. Med. Sci. – 2015. – Vol. 12, № 5. – Р. 387–396.

~113 ~

195.Park, H. Use of Oral Isotretinoin in the Management of Rosacea

/H. Park, J. Q. Del Rosso // J. Clin. Aesthet. Dermatol. – 2011. – Vol. 4, № 9. – Р. 54–61.

196.Picardo M. Skin microbiome and skin disease: the example of rosacea / M. Picardo, M. Ottaviani // J. Clin. Gastroenterol. – 2014. –

Vol. 48, № 1. – Р. 85–86.

197.Plasma reactive oxygen species activity and antioxidant potential levels in rosacea patients: correlation with seropositivity to Helicobacter

/F. C. Powell // Cutis. – 2004. – Vol. 74, № 3. – P. 9–12, 32–34.

199.Prevalence of skin diseases in a cohort of 48,665 employees in Germany / I. Schaefer [et al.] // Dermatology – 2008. – Vol. 217, № 2. – P. 169 – 172.

200.Proand anti-inflammatory forms of interleukin-1 in the tear fluid

and conjunctiva of patients with dry-eye disease / A. Solomon [et al.]

//Invest. Ophthalmol. Vis. Sci. – 2001. – Vol. 42, № 10. – Р. 2283–2292.

201.Reactive oxygen intermediates increase vascular endothelial

growth factor expression in vitro and in vivo / M. Kuroki [et al.]

//J. Clin. Invest. – 1996. – Vol. 98, № 7. – Р. 1667–1675.

202.Reactive oxygen species in tumor necrosis factoralphaactivated primary human keratinocytes: implications for psoriasis and inflammatory skin disease / С. N. Young [et al.] // J. Invest. Dermatol. – 2008. –

Vol. 128, № 11. – Р. 2606–2614.

203. Rebora, A. Helicobacter pylori in patients with rosacea / A. Rebora, F. Drago, A. Picciotto // Am. J. Gastroenterol. – 1994. – Vol. 89, № 9. – Р. 1603-1604.

204.Redox thiol status plays a central role in the mobilization and metabolism of nitric oxide in human red blood cells / J. P. L. Almeida [et al.]

//Cell. Biol. Int. – 2009. – Vol. 33, № 3. – Р. 268–275.

205.Reflectance confocal microscopy for monitoring the density of

Demodex mites in patients with rosacea before and after treatment

/E. C. Sattler [et al.] // Br. J. Dermatol. – 2015. – Vol. 173, № 1. – Р. 69–75.

206.Regulation of VEGF expression in cultured keratrinocytes:

Implications for normal and impaired wound healing / S. Frank [et al.]

//J. Biol. Chem. – 1995. – Vol. 270, № 21. – Р. 12607–12613.

~115 ~

207.Report of the Consensus Conference on Acne Classification, Washington, D.C., March 24-25 1990 / P. E. Pochi [et al.] // J. Am. Acad. Dermatol. – 1991. – Vol. 24, № 3. – P. 495–500.

208.Risk factors associated with rosacea / K. Abram [et al.] // J. Eur. Acad. Dermatol. Venereol. – 2010. – Vol. 24, № 5. – P. 565–571.

209.Robledo, M. A. Hypothesis of demodicidosis rosacea flushing etiopathogenesis / M. A. Robledo, M. Orduz // Med. Hypotheses. – 2015. –

Vol. 84, № 4. – P. 408–412.

210.Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis / C. S. Sander [et al.] // Int. J. Dermatol. – 2004. – Vol. 43,

№5. – Р. 326–335.

211.Rosacea – global diversity and optimized outcome: proposed

international consensus from the Rosacea International Expert Group

/B. E. Elewski [et al.] // J. Eur. Acad. Dermatol. Venereol. – 2011. – Vol. 25, № 2. – Р. 188–200.

212.Rosacea: The cytokine and chemokine network / P. A. Gerber [et al.] // J. Investig. Dermatol. Symp. Proc. – 2011. – Vol. 15, № 1. – Р. 40–47.

213.Rosacea treatment with intermediate-dose isotretinoin: follow-up with erythema and sebum measurements / M. Uslu [et al.] // Acta Derm. Venereol. – 2012. – Vol. 92, № 1. – Р. 73–77.

214.Sadick, N. A study to determine the effect of combination blue (415 nm) and near-infrared (830 nm) light-emitting diode (LED) therapy for moderate acne vulgaris / N. Sadick // J. Cosmet. Laser Ther. – 2009. –

Vol. 11, № 2. – Р. 125–128.

215.Schauber, J. Expanding the roles of antimicrobial peptides in skin: alarming and arming keratinocytes / J. Schauber, R. L. Gallo // J. Invest. Dermatol. – 2007. – Vol. 127, № 3. – Р. 510–512.

216.Sedlak, J. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent / J. Sedlak, R. H. Lindsay // Anal. Biochem. – 1968. – Vol. 25, № 1. – Р. 192–205.

217.Sensitive skin in the American population: prevalence, clinical data, and role of the dermatologist / L. Misery [et al.] // Int. J. Dermatol. – 2011. – Vol. 50, № 8. – Р. 961–967.

218.Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication / A. Parodi [et al.] // Clin. Gastroenterol. Hepatol. – 2008. – Vol. 6, № 7. – Р. 759–764.

219.Standard classification of rosacea: Report of the National Rosacea Sosiety Expert Committee on the Classsification and Standing of Rosacea

/J. Wilkin [et al.] // J. Am. Acad. Dermatol. – 2002. – Vol. 15. – P. 584–587.

~116 ~

220.Standard grading system for rosacea: Report of the National Rosacea Sosiety Expert Committee on the classsification and standing of rosacea / J. Wilkin [et al.] // J. Am. Acad. Dermatol. – 2004. – Vol. 50. – P. 907–912.

221.Staphylococcus epidermidis: a possible role in the pustules of rosacea / M. Whitfeld [et al.] // J. Am. Acad. Dermatol. – 2011. – Vol. 64,

№ 1. – Р. 49–52.

222.Steinhoff, M. New insights into rosacea pathophysiology: a review of recent findings / M. Steinhoff, J. Schauber, J. J. Leyden // J. Am. Acad. Dermatol. – 2013. – Vol. 69, № 6. – Р. 15–26.

223.Symptom severity and psychological sequelae in rosacea: results of a survey / D. Böhm [et al.] // Psychol. Health Med. – 2014. – Vol. 19, № 5.

– Р. 586–591.

224.Systemic isotretinoin in the treatment of rosacea – doxycycline –

and placebo-controlled, randomized clinical study / H. Gollnick [et al.]

//J. Dtsch. Dermatol. Ges. – 2010. – Vol. 8, № 7. – Р. 505–515.

225.Szlachcic, A. The link between Helicobacter pylori infection and rosacea / A. Szlachcic // J. Eur. Acad. Dermatol. Venereol. – 2002. – Vol. 16, № 4. – Р. 328–333.

226.Tan, J. Rosacea: current state of epidemiology / J. Tan, M. Berg

//J. Am. Acad. Dermatol. – 2013. – Vol. 69, № 6. – Р. 27–35.

227.Taylor, S. L. Sensitive fluorometric method for tissue tocopherol analysis / S. L. Taylor, M. P. Lamden, A. L. Tappel // Lipids. – 1976. –

Vol. 11, № 7. – P. 530–538.

228.The effect of azithromycin on reactive oxygen species in rosacea / O. Bakar [et al.] // Clin. Exp. Dermatol. – 2007. – Vol. 32, № 2. – P. 197–200.

229.The fatty acid profile of the skin surface lipid layer in papulopustular rosacea / S. Ní Raghallaigh [et al.] // Br. J. Dermatol. – 2012.

– Vol. 166, № 2. – Р. 279–287.

230.The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities / B. Aksoy [et al.] // Br. J. Dermatol. – 2010. – Vol. 163, № 4. – Р. 719–725.

231.The mechanism of interaction of ceruloplasmin with superoxide radicals / A. G. Sergeev [et al.] // Int. J. Biochem. – 2000. – Vol. 25, № 11. – Р. 1549–1554.

232.Theobald, K. Anti-inflammatory dose doxycycline (40 mg controlled-release) confers maximum anti-inflammatory efficacy in rosacea

~117 ~

/ K. Theobald, M. Bradshaw, J. Leyden // Skinmed. – 2007. – Vol. 6, № 5. – Р. 221–226.

233.The potential role of microorganisms in the development of rosacea / E. Lazaridou [et al.] // J. Dtsch. Dermatol. Ges. – 2011. –

Vol. 9, № 1. – Р. 21–25.

234.The quality of life impact of acne and rosacea compared to other major medical conditions / N. D. Cresce [et al.] // J. Drugs Dermatol. – 2014.

–Vol. 13, № 6. – Р. 692–697.

235.The role of free oxygen radicals in the aetiopathogenesis of rosacea / M. O. Oztas [et al.] // Clin. Exp. Dermatol. – 2003. – Vol. 28, № 2. – P. 188–192.

236.The seroprevalence of Helicobacter pylori and nitric oxide in acne

rosacea / M. A. Gürer [et al.] // Int. J. Dermatol. – 2002. – Vol. 41,

№11. – P. 768–770.

237.The skin microbiome: Associations between altered microbial communities and disease / L. S. Weyrich [et al.] // Australas. J. Dermatol. – 2015. – Vol. 56, № 4. – Р. 268–274.

238.Tisma, V. S. The role of oxidative stress and iron in pathophysiology of rosacea / V. S. Tisma, M. Poljak-Blazi // Lijec. Vjesn. – 2011. – Vol. 133, № 7/8. – Р. 288–291.

239.Topographical and temporal diversity of the human skin microbiome

/ E. A. Grice [et al.] // Science. – 2009. – Vol. 324 (5931). – P. 1190–1192.

240.Two randomized phase III clinical trials evaluating antiinflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea / J. Q. Del Rosso [et al.] // J. Am. Acad. Dermatol. – 2007. – Vol. 56, № 5. – Р. 791–802.

241.van Zuuren, E. J. Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments / E. J. van Zuuren, Z. Fedorowicz // Br. J. Dermatol. – 2015. – Vol. 173, № 3. – Р. 651–662.

242.Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries / D. D. Ku [et al.] // Am. J. Physiol. – 1993. –

Vol. 265, № 2. – Р. 586–592.

243.Ultraviolet B and H2O2 are potent inducers of vascular

244.Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis / O. Distler [et al.] // Circ. Res. – 2004. – Vol. 95, № 1. – Р. 109– 116.

245.Uta, S. Treatment of rosacea with ketoconazole / S. Uta, Ü. Ünver

//J. Eur. Acad. Dermatol. Venereol. – 1997. – Vol. 8, № 1. – P. 69–70.

246.UV induces VEGF through a TNF-alpha independent pathway / M. G. Kosmadaki [et al.] // FASEB J. – 2003. – Vol. 17, № 3. – Р. 446–448.

247. Weinkle, A. P. Update on the Management of Rosacea / A. P. Weinkle, V. Doktor, J. Emer // Plast. Surg. Nurs. – 2015. – Vol. 35,

№4. – Р. 184–202.

248.Weinstock, L. B. Rosacea and small intestinal bacterial

249.Wollina, U. Subantimicrobial-dose doxycycline monohydrate in dermatology / U. Wollina // Wien. Med. Wochenschr. – 2015. – Vol. 165,

№23/24. – Р. 499–503.

250.Yarmolik, A. Rola wskaznikow peroksydacji lipidow I czynnika

~ 119 ~

Научное издание

Хворик Дмитрий Федорович Ярмолик Елена Сергеевна

ПАПУЛО-ПУСТУЛЕЗНАЯ ФОРМА РОЗАЦЕА У ЖЕНЩИН:

этиопатогенез, клиника, диагностика, лечение

Монография

Ответственный за выпуск С. Б. Вольф

Компьютерная верстка С. В. Петрушиной Корректор Л. С. Засельская

Подписано в печать 04.05.2017. Формат 60х84/16. Бумага офсетная. Гарнитура Times New Roman. Ризография.

Усл. печ. л. 6,97. Уч.-изд. л. 5,36. Тираж 50 экз. Заказ 36.

Издатель и полиграфическое исполнение учреждение образования

«Гродненский государственный медицинский университет». ЛП № 02330/445 от 18.12.2013.

Ул. Горького, 80, 230009, г. Гродно.

~ 120 ~